Neuroscience

Resetting the immune system: HMOs as a promising treatment for Gut-Brain Axis disorders

Emil Chuang, Chief Medical Officer at Intrinsic Medicine, explores the growing understanding of gut-brain axis disorders and the potential of Human Milk Oligosaccharides (HMOs) in their treatment. 

Gut microbiota might be linked to brain development in preterm infants

A study revealed a link between gut microbiota composition and brain development in preterm infants, suggesting that specific bacteria and their metabolites can influence neurodevelopment.

Small study uncovers gut microbiota differences in schizophrenia

New research has now uncovered differences in the gut microbiota composition between people with the condition and those without.

Study links gut bacteria to Alzheimer’s, uncovering potential new targets

The findings suggest that gut microbes and LPC are potential therapeutic targets for Alzheimer's disease.

MaaT Pharma reports positive Phase 1b results for MaaT033 in ALS, setting the stage for future advances

A significant milestone for both microbiome research and neurodegenerative diseases.

EnteroBiotix’s EBX-102 shows promising Phase 1b results for liver cirrhosis treatment

New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.

The gut microbiome is pivotal in the anorexia nervosa’s appetite

The gut microbiome clearly influenced the expression of 8 peptides involved in appetite regulation, which, along with diet and physical activity, plays a pivotal role in the development of anorexia…

Stress alters the gut microbiota and increases infection risk, mouse study suggests

The findings suggest that the vagus nerve and amygdala are crucial in maintaining microbiota balance and could serve as targets for mitigating stress-related gut and immune conditions.

NIH grant fuels groundbreaking research on polyphenols, Alzheimer’s prevention, and the brain-gut-microbiome connection

Arpana Church (UCLA): ‘We’re hoping to better understand the role of dietary polyphenols in slowing the development of cognitive decline and how this is all influenced by the gut microbiome’.

Exploring gut microbiota in Autism Spectrum Disorder: a metagenomic case study comparing an ASD patient with an at-risk infant sibling

Microbiomepost conducted an exclusive interview with Martina Piacente, from Ebris - European Biomedical Research Institute of Salerno, about the role of gut microbiome in Autism Spectrum Disorder.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top